White Paper

Chromogenic Multiplex IHC Assay


mIHC white paper


Key topics discussed:

  • Why choose chromogenic multiplex immunohistochemistry?
  • Steps to follow to develop mIHC assays
  • Our CD8/Granzyme B (GZMB)/FOXP3 assay and its clinical applications
  • Challenges and future developments in the field

Why Choose CellCarta for your Histopathology Assays

We perform tissue analysis for biomarkers, clinical testing, and companion diagnostics using cutting-edge technologies and capabilities such as multiplex IHC and RareCyte. By supporting our team of in-house pathologists with AI we transform tissue biology into actionable data.

Contact us

Download our white paper